Methods for the treatment of pulmonary arterial hypertension with activin receptor type IIa (ACTRIIA) proteins and / or their variants
CO20260009926A2Pending Publication Date: 2026-07-21MERCK SHARP & DOHME LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- MERCK SHARP & DOHME LLC
- Filing Date
- 2026-07-06
- Publication Date
- 2026-07-21
Abstract
The present invention relates to therapies useful for the treatment of pulmonary arterial hypertension. In particular, the invention relates to a method for treating pulmonary arterial hypertension comprising administering to a patient in need an ActRIIA-Fc fusion protein or a variant thereof, using the dosage regimens specified herein.
Need to check novelty before this filing date? Find Prior Art